참고: PassTIP에서 Google Drive로 공유하는 무료 2026 Nursing ACNS 시험 문제집이 있습니다: https://drive.google.com/open?id=1i-o8LcfacyM0IZM5OUzic7uHWLJt31IQ
Nursing인증 ACNS시험은 멋진 IT전문가로 거듭나는 길에서 반드시 넘어야할 높은 산입니다. Nursing인증 ACNS시험문제패스가 어렵다한들PassTIP덤프만 있으면 패스도 간단한 일로 변경됩니다. PassTIP의Nursing인증 ACNS덤프는 100%시험패스율을 보장합니다. Nursing인증 ACNS시험문제가 업데이트되면Nursing인증 ACNS덤프도 바로 업데이트하여 무료 업데이트서비스를 제공해드리기에 덤프유효기간을 연장해는것으로 됩니다.
| Section | Weight | Objectives |
|---|---|---|
| Health Care Systems and Policy | 5% | - Resource Management - Regulatory and Policy Frameworks - Healthcare Delivery Models |
| Role and Professional Responsibility | 33% | - Clinical Leadership and Consultation - Quality Improvement and Safety - Evidence-Based Practice and Research - Education and Mentorship - Ethics and Legal Aspects |
| Clinical Practice | 46% | - Health Promotion and Disease Prevention - Pharmacologic and Nonpharmacologic Management - Health Assessment and Diagnosis - Evaluation of Outcomes - Care Planning and Implementation |
| APRN Core Competencies | 16% | - Advanced Pathophysiology - Advanced Health Assessment - Advanced Pharmacology |
PassTIP 는 전문적으로 Nursing전문인사들에게 도움을 드리는 사이트입니다.많은 분들의 반응과 리뷰를 보면 우리PassTIP의 ACNS제품이 제일 안전하고 최신이라고 합니다. PassTIP의 학습가이드는 아주 믿음이 가는 문제집들만 있으니까요. PassTIP 덤프의 문제와 답은 모두 제일 정확합니다. 왜냐면 우리의 전문가들은 매일 최신버전을 갱신하고 있기 때문입니다.
질문 # 85
Of the following which is a promotility agent you'd prescribe for your patient's gastrointestinal disorder?
정답：B
설명：
To answer the question about which drug is a promotility agent that could be prescribed for a patient's gastrointestinal disorder, it is essential to understand what each listed medication is typically used for and how they function.
**Metoclopramide:** This is the correct answer to the question. Metoclopramide is a well-known promotility agent used primarily to treat nausea, vomiting, and gastroparesis (delayed gastric emptying). It works by enhancing the motility of the stomach and intestines, which helps speed the movement of food through the gastrointestinal tract. It acts by blocking dopamine receptors and increasing the release of acetylcholine in the gut, which stimulates gastric motility and accelerates gastric emptying. It's often prescribed under the brand name Reglan.
**Senna:** This is not a promotility agent but rather a stimulant laxative. Senna works by irritating the lining of the bowel, which causes a laxative effect. It is primarily used to treat constipation and to clear the bowel before diagnostic tests such as colonoscopy. Senna does not enhance the motility of the upper gastrointestinal tract and thus is not useful as a promotility agent.
**Tegaserod:** This medication is a selective 5-HT4 receptor agonist that was used to treat irritable bowel syndrome (IBS) with constipation and chronic idiopathic constipation. It works by mimicking the action of serotonin at the 5-HT4 receptor, enhancing peristaltic reflex and intestinal secretion, which helps increase gastrointestinal motility. However, it is not typically classified as a promotility agent like Metoclopramide, and its use has been limited due to concerns over cardiovascular side effects.
**Alosetron:** This drug is a selective 5-HT3 receptor antagonist used primarily for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women. Alosetron works by blocking serotonin receptors in the gastrointestinal tract, reducing bowel motility, and enhancing absorption. It effectively manages symptoms of IBS but does not promote motility; rather, it slows it down in cases of diarrhea-predominant IBS.
In conclusion, among the options provided, Metoclopramide is the only appropriate promotility agent for treating gastrointestinal disorders that involve delayed gastric emptying or reduced motility. The other listed drugs serve different purposes and act through mechanisms that do not enhance gastrointestinal motility in the way promotility agents like Metoclopramide do.
질문 # 86
Which of the medications listed below could potentially exacerbate CHF in a susceptible individual?
정답：B
설명：
The question asks which medication might worsen congestive heart failure (CHF) in a susceptible individual. To answer this, we need to understand the impact of each listed drug on heart function, particularly in the context of CHF.
Furosemide is a loop diuretic commonly used in the treatment of CHF. It works by helping the kidneys eliminate unneeded water and salt from the body through urine. This reduces the volume of fluid circulating through the blood vessels, decreasing the load on the heart. Therefore, furosemide is generally beneficial for CHF patients as it helps alleviate symptoms such as swelling and shortness of breath, rather than exacerbating CHF.
Metoprolol is a beta-blocker that is used to manage several cardiovascular conditions, including CHF. It works by blocking beta-adrenergic receptors in the heart, which slows down the heart rate and reduces the force of the heart muscle's contractions. Initially, it was thought that beta-blockers were not safe for CHF patients due to their effect on reducing cardiac output. However, long-term use has been shown to improve the function of the heart and increase survival rates in CHF patients. Short-term effects, though, might include a decrease in cardiac output, which can be problematic in CHF patients who are unstable or in acute distress.
Metformin is primarily a medication for type 2 diabetes, not directly affecting heart function or cardiac output. It is generally considered safe in patients with CHF unless there are complicating factors such as kidney dysfunction, which is a contraindication due to the risk of lactic acidosis.
Acetaminophen, commonly used for pain and fever, has no direct impact on cardiac output or heart function. It is considered safe in recommended doses for patients with CHF as it does not exacerbate heart failure symptoms.
From the medications listed, while metoprolol might initially pose some risk due to its effect on cardiac output, it is generally beneficial in long-term CHF management. The other medications, furosemide, metformin, and acetaminophen, do not typically exacerbate CHF. In fact, furosemide is often part of the therapeutic regimen for managing CHF symptoms. Therefore, the correct answer depends significantly on the specific circumstances and stability of the CHF patient when considering metoprolol. For a patient in acute CHF distress or not yet stabilized on chronic CHF therapy, metoprolol could potentially exacerbate the condition temporarily.
질문 # 87
A 76-year-old African-American female patient presents with complaints of dyspnea, fatigue, cough, and dependent edema that has been worsening over the past few days. In planning treatment, the ACNS considers:
정답：A
설명：
A 76-year-old African-American female patient presents with symptoms of dyspnea (shortness of breath), fatigue, cough, and dependent edema. These symptoms are concerning and could potentially indicate a serious underlying condition such as heart failure or pulmonary edema. Dyspnea and fatigue may suggest reduced cardiac output, while cough and edema (swelling, typically in the lower limbs due to fluid accumulation) can be associated with fluid congestion, a common feature in heart failure.
Given the severity and the nature of her symptoms, especially in an elderly patient, it is critical to accurately diagnose and manage the underlying cause promptly. The initial step recommended is a referral for hospitalization for evaluation of heart function. This decision is based on the need for a thorough assessment which typically includes diagnostic tests such as echocardiography, electrocardiograms, and possibly cardiac biomarkers. These tests help in confirming the diagnosis, assessing the severity of the condition, and planning appropriate management.
In the hospital, the patient can be monitored closely for any signs of worsening heart function, and immediate interventions can be applied if necessary. Treatment might include diuretics to manage fluid overload, as well as other medications to support heart function depending on the specific findings related to the cause of the heart failure.
The prescription of furosemide (Lasix) 40 mg PO once daily might seem a reasonable option to manage symptoms by reducing fluid overload. However, merely prescribing a diuretic without a comprehensive evaluation risks insufficient treatment and potential complications due to underlying untreated heart conditions. Therefore, while furosemide is part of the management for heart failure, initiating it should ideally occur after a hospital-based evaluation.
Other options such as the addition of a calcium channel blocker or streptokinase therapy are not suitable in this scenario. Calcium channel blockers are generally not beneficial in the treatment of heart failure and can sometimes worsen the condition depending on the type and stage of heart failure. Streptokinase, a thrombolytic agent, is used to dissolve clots typically in the setting of a myocardial infarction (heart attack) and not in heart failure unless a heart attack is suspected as the underlying cause.
In conclusion, the recommendation for hospitalization for evaluation of heart function is the most appropriate and safe approach given the patient's symptoms and potential risks. This approach allows for comprehensive assessment and tailored treatment, which are crucial in managing elderly patients with possible acute heart conditions.
질문 # 88
Of the following, which is an antipsychotic that can be used to treat neurological disorders?
정답：D
설명：
Among the medications listed, Pimozide is identified as an antipsychotic that can be used to treat neurological disorders. Pimozide primarily functions as an antipsychotic drug, which is typically used to manage symptoms associated with conditions like Tourette's syndrome. This particular neurological disorder is characterized by involuntary, repetitive movements and vocalizations known as tics. By blocking the dopamine receptors in the brain, Pimozide helps to control the expressions of these tics, thereby providing relief to individuals suffering from this condition.
On the other hand, the other drugs mentioned serve different primary purposes in the treatment of neurological and other medical conditions. Hydantoin, for example, is widely recognized as an anticonvulsant. It is primarily used to manage and prevent seizures in the treatment of epilepsy. By stabilizing the electrical activity in the brain, it helps to prevent the excessive and abnormal brain cell activity that causes seizures.
Flurazepam belongs to the class of drugs known as benzodiazepines. It is generally prescribed for the short-term treatment of insomnia. Benzodiazepines function by enhancing the effect of the neurotransmitter GABA, which results in sedative, muscle-relaxant, anticonvulsant, and anxiolytic effects. Though not directly treating neurological disorders, its sedative properties can indirectly aid patients with neurological conditions that may experience sleep disturbances.
Lastly, Bromocriptine is a dopamine agonist. This medication is typically used in the treatment of Parkinson's disease, a neurological disorder characterized by tremors, stiffness, and slow movement. Bromocriptine works by stimulating dopamine receptors in the brain, which helps to alleviate these symptoms. It is also used to treat disorders related to high levels of prolactin hormone and certain types of acromegaly.
In summary, while all these medications can be associated with the treatment of neurological issues, Pimozide stands out as the specific antipsychotic used primarily for managing symptoms of neurological disorders like Tourette's syndrome. Each medication, however, plays a crucial role in addressing different aspects of neurological and other health conditions.
질문 # 89
What is normal ICP?
정답：C
설명：
Intracranial pressure (ICP) refers to the pressure within the skull and thus the brain tissue and cerebrospinal fluid (CSF). Under normal conditions, ICP is typically 15 millimeters of mercury (mm Hg) or below. This pressure range is essential for maintaining the proper cerebral blood flow and ensuring that the brain is adequately nourished with oxygen and nutrients while also disposing of carbon dioxide and other metabolic wastes.
ICP can be influenced by various factors such as head injuries, brain tumors, infections, and other conditions that can lead to brain swelling or an increase in CSF. When ICP exceeds 15 mm Hg, it can potentially disrupt the delicate balance of brain function and blood supply, leading to symptoms such as headache, nausea, vomiting, altered mental status, and in severe cases, brain damage or death.
Medical professionals monitor ICP closely in patients who are at risk of elevated ICP. If the pressure rises to critical levels, typically considered above 20 mm Hg, immediate intervention is required to reduce the pressure. This might involve medication to reduce brain swelling, draining CSF to temporarily relieve pressure, or surgery in severe cases.
Monitoring and managing ICP is crucial in various neurological conditions to prevent complications and ensure patient safety. Thus, understanding and maintaining normal ICP levels, ideally at or below 15 mm Hg, is a fundamental aspect of neurocritical care.
질문 # 90
......
Nursing인증ACNS시험준비를 하고 계시다면PassTIP에서 출시한Nursing인증ACNS덤프를 제일 먼저 추천해드리고 싶습니다. PassTIP제품은 여러분들이 제일 간편한 방법으로 시험에서 고득점을 받을수 있도록 도와드리는 시험동반자입니다. Nursing인증ACNS시험패는PassTIP제품으로 고고고!
ACNS완벽한 인증자료: https://www.passtip.net/ACNS-pass-exam.html
2026 PassTIP 최신 ACNS PDF 버전 시험 문제집과 ACNS 시험 문제 및 답변 무료 공유: https://drive.google.com/open?id=1i-o8LcfacyM0IZM5OUzic7uHWLJt31IQ